Literature DB >> 19640858

Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis.

J S Cargill1, M Upton.   

Abstract

AIMS: To examine the response of Staphylococcus epidermidis isolates from prosthetic orthopaedic infections to vancomycin concentrations below the minimum inhibitory concentration.
METHODS: Staphylococcal biofilms were grown in 96-well flat-bottomed cell culture plates under a variety of culture conditions and stained using an ammonium crystal violet solution. Optical density (450 nm wavelength) was recorded to estimate the biofilm density for each strain. Population analysis and time-kill studies were also performed on selected isolates.
RESULTS: A range of responses were observed, including increased biofilm density at drug concentrations approaching the minimum inhibitory concentration. This increased density was associated with the presence of a more resistant population identified on population analysis but without an apparent effect on the time-kill curves.
CONCLUSIONS: The ability of some strains to show increased biofilm density could be a factor in the failure of vancomycin therapy reported in some cases. The demonstration that low concentrations of vancomycin may increase the density of newly forming S epidermidis biofilms may indicate an area of potential concern in the use of vancomycin in orthopaedic implants and intravascular catheter locks, and may partially account for some cases of treatment failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640858     DOI: 10.1136/jcp.2009.069021

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin.

Authors:  Natalya Doroshenko; Boo Shan Tseng; Robert P Howlin; Jill Deacon; Julian A Wharton; Philipp J Thurner; Brendan F Gilmore; Matthew R Parsek; Paul Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

2.  Structural study of TcaR and its complexes with multiple antibiotics from Staphylococcus epidermidis.

Authors:  Yu-Ming Chang; Wen-Yih Jeng; Tzu-Ping Ko; Yao-Jen Yeh; Cammy K-M Chen; Andrew H-J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

3.  Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  Wessam Abdelhady; Arnold S Bayer; Kati Seidl; Cynthia C Nast; Megan R Kiedrowski; Alexander R Horswill; Michael R Yeaman; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

Review 4.  Novel Treatment Strategies for Biofilm-Based Infections.

Authors:  Claudia Vuotto; Gianfranco Donelli
Journal:  Drugs       Date:  2019-10       Impact factor: 9.546

5.  Extracellular DNA-dependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics.

Authors:  Jeffrey B Kaplan; Saïd Jabbouri; Irina Sadovskaya
Journal:  Res Microbiol       Date:  2011-03-12       Impact factor: 3.992

6.  Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.

Authors:  Fernanda Gomes; Pilar Teixeira; Howard Ceri; Rosário Oliveira
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375

7.  Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci.

Authors:  Jeffrey B Kaplan; Karen LoVetri; Silvia T Cardona; Srinivasa Madhyastha; Irina Sadovskaya; Saïd Jabbouri; Era A Izano
Journal:  J Antibiot (Tokyo)       Date:  2011-12-14       Impact factor: 2.649

Review 8.  Biofilm Disrupting Technology for Orthopedic Implants: What's on the Horizon?

Authors:  Alexander Connaughton; Abby Childs; Stefan Dylewski; Vani J Sabesan
Journal:  Front Med (Lausanne)       Date:  2014-08-15

9.  Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm.

Authors:  Orit Oettinger-Barak; Stuart G Dashper; Deanne V Catmull; Geoffrey G Adams; Michael N Sela; Eli E Machtei; Eric C Reynolds
Journal:  J Oral Microbiol       Date:  2013-05-08       Impact factor: 5.474

10.  Farnesol in combination with N-acetylcysteine against Staphylococcus epidermidis planktonic and biofilm cells.

Authors:  Fernanda Gomes; Bruna Leite; Pilar Teixeira; Joana Azeredo; Rosário Oliveira
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.